Primary Site >> Colorectal Cancer

Gene >> COL4A1

Journal: Cancer Res. 2007 Jul 15;67(14):6899-906.
Title: Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist.
Author: Ayers, Mark|Fargnoli, Joseph|Lewin, Anne|Wu, Qiuyan|Platero, J Suso
PMID: 17638901
Journal: Ai Zheng. 2008 Oct;27(10):1039-43.
Title: [Inhibitory effects of transfection of arresten gene on liver metastasis from colorectal cancer in nude mice].
Author: Long, Miao-Yun|Li, Hong-Hao|Xu, Jun-Yao|Lai, Dong-Min|Weng, Zhen-Hong
PMID: 18851782
Journal: Chin Med Sci J. 2012 Mar;27(1):11-7.
Title: The inhibitory effects of arresten protein on tumor formation.
Author: Lv, Yi|Zheng, Jin-Ping
PMID: 22734208
Journal: Oncotarget. 2015 Oct 6;6(30):29929-46.
Title: Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics.
Author: Qiao, Jie|Fang, Cai-Yun|Chen, Sun-Xia|Wang, Xiao-Qing|Cui, Shu-Jian|Liu, Xiao-Hui|Jiang, Ying-Hua|Wang, Jie|Zhang, Yang|Yang, Peng-Yuan|Liu, Feng
PMID: 26338966
Journal: Oncotarget. 2017 Nov 10;8(61):104508-104524.
Title: hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC.
Author: Zhang, Shitong|Jin, Jianjun|Tian, Xiaoxiao|Wu, Lijuan
PMID: 29262657